Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Accelerated Approval
View:
Post by jmm1228 on Jun 30, 2023 10:49am

Accelerated Approval

I am no expert on the subject but it appears to me that AA can and has been granted before BTD. The AA guidelines favor cancer treatments, especially those with low adverse adverse reactions. Ruvidar should meet these  standards.
Comment by Oilminerdeluxe on Jun 30, 2023 11:22am
Hopefully some action will happen soon, whatever that will be. Money is needed, BTD application is close. Perhaps they will work in tandem somehow.
Comment by chry200030 on Jun 30, 2023 1:28pm
Very surprised TLT is not over $1 already.  With these milestones coming very soon, this stock has nowhere to go but UP. It's a no brainer for those buying here.  For sellers ..??
Comment by DJDawg on Jun 30, 2023 2:02pm
I think the price is stalled for a few reasons - historically there have been PP's at 0.25 so I think many expect that a PP offering may be announced in which case, if the stock price is above 0.25, certain investors may just sell on the open market to get in on the PP at 0.25 (plus get a warrant usually) - A while ago some large asks got planted on the 2nd order and just sit there. Right now ...more  
Comment by Rumpl3StiltSkin on Jun 30, 2023 1:28pm
AA can and has been granted after FT before. In TLTs case BTD should speed things up. Of Course, TLT hasn't had the data until recently to go for BTD or AA. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250